Peptide Hormones in Lung Cancer Editor - 8 Angebote vergleichen
| Preise | 2013 | 2014 | 2015 | 2020 |
|---|---|---|---|---|
| Schnitt | € 76,27 | € 70,36 | € 96,30 | € 86,99 |
| Nachfrage |
1
Symbolbild
Peptide Hormones in Lung Cancer (Paperback) (1985)
DE PB NW RPISBN: 9783540155041 bzw. 354015504X, in Deutsch, Springer-Verlag Berlin and Heidelberg GmbH Co. KG, Germany, Taschenbuch, neu, Nachdruck.
Lieferung aus: Deutschland, Versandkostenfrei.
Von Händler/Antiquariat, The Book Depository EURO [60485773], Slough, United Kingdom.
Language: English Brand New Book ***** Print on Demand *****.The incidence of lung cancer has reached epidemic proportions throughout the civilized world. One indication of the dimensions of this problem is that in the United States lung cancer has become the leading cause of cancer death in women as well as men. In 1912 there was a nearly complete consensus of opinion that primary malignant neoplasms of the lung (were one) of the rarest forms of disease, according to Adler. By 1937, however, it had become clear that the incidence of lung cancer was increasing significantly; this increase has been progressive ever since. It is now well known that some lung cancers give rise to a variety of hormones which, at times, produce clinical manifestations. The association of hormone production with a nonendocrine tumor raises many questions, the answers to which may shed some light on the etiology of this prevalent form of cancer. This fascinating prob- lem has stimulated a wide variety of studies in both the clinical and the basic sciences. A number of the more recent studies in this field were discussed at the International Symposium on Peptide Hor- mones and Lung Cancer held in Marburg, West Germany, on June 18-20, 1984. This volume contains the papers that were pre- sented on this occasion. Softcover reprint of the original 1st ed. 1985.
Von Händler/Antiquariat, The Book Depository EURO [60485773], Slough, United Kingdom.
Language: English Brand New Book ***** Print on Demand *****.The incidence of lung cancer has reached epidemic proportions throughout the civilized world. One indication of the dimensions of this problem is that in the United States lung cancer has become the leading cause of cancer death in women as well as men. In 1912 there was a nearly complete consensus of opinion that primary malignant neoplasms of the lung (were one) of the rarest forms of disease, according to Adler. By 1937, however, it had become clear that the incidence of lung cancer was increasing significantly; this increase has been progressive ever since. It is now well known that some lung cancers give rise to a variety of hormones which, at times, produce clinical manifestations. The association of hormone production with a nonendocrine tumor raises many questions, the answers to which may shed some light on the etiology of this prevalent form of cancer. This fascinating prob- lem has stimulated a wide variety of studies in both the clinical and the basic sciences. A number of the more recent studies in this field were discussed at the International Symposium on Peptide Hor- mones and Lung Cancer held in Marburg, West Germany, on June 18-20, 1984. This volume contains the papers that were pre- sented on this occasion. Softcover reprint of the original 1st ed. 1985.
2
Peptide Hormones in Lung Cancer (1984)
~EN PB NWISBN: 9783540155041 bzw. 354015504X, vermutlich in Englisch, Springer, Berlin, Taschenbuch, neu.
Lieferung aus: Deutschland, Versandkosten nach: Deutschland, Versandkostenfrei.
Von Händler/Antiquariat, buecher.de GmbH & Co. KG, [1].
The incidence of lung cancer has reached epidemic proportions throughout the civilized world. One indication of the dimensions of this problem is that in the United States lung cancer has become the leading cause of cancer death in women as well as men. In 1912 there was a "nearly complete consensus of opinion that primary malignant neoplasms of the lung (were one) of the rarest forms of disease," according to Adler. By 1937, however, it had become clear that the incidence of lung cancer was increasing significantly this increase has been progressive ever since. It is now well known that some lung cancers give rise to a variety of hormones which, at times, produce clinical manifestations. The association of hormone production with a "nonendocrine" tumor raises many questions, the answers to which may shed some light on the etiology of this prevalent form of cancer. This fascinating prob lem has stimulated a wide variety of studies in both the clinical and the basic sciences. A number of the more recent studies in this field were discussed at the International Symposium on Peptide Hor mones and Lung Cancer held in Marburg, West Germany, on June 18-20, 1984. This volume contains the papers that were pre sented on this occasion. xii, 248 S. 52 SW-Abb. Versandfertig in 6-10 Tagen, Softcover, Neuware, Offene Rechnung (Vorkasse vorbehalten).
Von Händler/Antiquariat, buecher.de GmbH & Co. KG, [1].
The incidence of lung cancer has reached epidemic proportions throughout the civilized world. One indication of the dimensions of this problem is that in the United States lung cancer has become the leading cause of cancer death in women as well as men. In 1912 there was a "nearly complete consensus of opinion that primary malignant neoplasms of the lung (were one) of the rarest forms of disease," according to Adler. By 1937, however, it had become clear that the incidence of lung cancer was increasing significantly this increase has been progressive ever since. It is now well known that some lung cancers give rise to a variety of hormones which, at times, produce clinical manifestations. The association of hormone production with a "nonendocrine" tumor raises many questions, the answers to which may shed some light on the etiology of this prevalent form of cancer. This fascinating prob lem has stimulated a wide variety of studies in both the clinical and the basic sciences. A number of the more recent studies in this field were discussed at the International Symposium on Peptide Hor mones and Lung Cancer held in Marburg, West Germany, on June 18-20, 1984. This volume contains the papers that were pre sented on this occasion. xii, 248 S. 52 SW-Abb. Versandfertig in 6-10 Tagen, Softcover, Neuware, Offene Rechnung (Vorkasse vorbehalten).
3
Peptide Hormones in Lung Cancer (1984)
~EN PB NWISBN: 9783540155041 bzw. 354015504X, vermutlich in Englisch, Springer Shop, Taschenbuch, neu.
Lieferung aus: Deutschland, Lagernd.
The incidence of lung cancer has reached epidemic proportions throughout the civilized world. One indication of the dimensions of this problem is that in the United States lung cancer has become the leading cause of cancer death in women as well as men. In 1912 there was a "nearly complete consensus of opinion that primary malignant neoplasms of the lung (were one) of the rarest forms of disease," according to Adler. By 1937, however, it had become clear that the incidence of lung cancer was increasing significantly; this increase has been progressive ever since. It is now well known that some lung cancers give rise to a variety of hormones which, at times, produce clinical manifestations. The association of hormone production with a "nonendocrine" tumor raises many questions, the answers to which may shed some light on the etiology of this prevalent form of cancer. This fascinating prob lem has stimulated a wide variety of studies in both the clinical and the basic sciences. A number of the more recent studies in this field were discussed at the International Symposium on Peptide Hor mones and Lung Cancer held in Marburg, West Germany, on June 18-20, 1984. This volume contains the papers that were pre sented on this occasion. Soft cover.
The incidence of lung cancer has reached epidemic proportions throughout the civilized world. One indication of the dimensions of this problem is that in the United States lung cancer has become the leading cause of cancer death in women as well as men. In 1912 there was a "nearly complete consensus of opinion that primary malignant neoplasms of the lung (were one) of the rarest forms of disease," according to Adler. By 1937, however, it had become clear that the incidence of lung cancer was increasing significantly; this increase has been progressive ever since. It is now well known that some lung cancers give rise to a variety of hormones which, at times, produce clinical manifestations. The association of hormone production with a "nonendocrine" tumor raises many questions, the answers to which may shed some light on the etiology of this prevalent form of cancer. This fascinating prob lem has stimulated a wide variety of studies in both the clinical and the basic sciences. A number of the more recent studies in this field were discussed at the International Symposium on Peptide Hor mones and Lung Cancer held in Marburg, West Germany, on June 18-20, 1984. This volume contains the papers that were pre sented on this occasion. Soft cover.
4
Peptide Hormones in Lung Cancer Klaus Havemann Editor (1984)
~EN PB NWISBN: 9783540155041 bzw. 354015504X, vermutlich in Englisch, Springer Berlin Heidelberg, Taschenbuch, neu.
Lieferung aus: Vereinigte Staaten von Amerika, Lagernd, zzgl. Versandkosten.
The incidence of lung cancer has reached epidemic proportions throughout the civilized world. One indication of the dimensions of this problem is that in the United States lung cancer has become the leading cause of cancer death in women as well as men. In 1912 there was a nearly complete consensus of opinion that primary malignant neoplasms of the lung (were one) of the rarest forms of disease, according to Adler. By 1937, however, it had become clear that the incidence of lung cancer was increasing significantly; this increase has been progressive ever since. It is now well known that some lung cancers give rise to a variety of hormones which, at times, produce clinical manifestations. The association of hormone production with a nonendocrine tumor raises many questions, the answers to which may shed some light on the etiology of this prevalent form of cancer. This fascinating prob­ lem has stimulated a wide variety of studies in both the clinical and the basic sciences. A number of the more recent studies in this field were discussed at the International Symposium on Peptide Hor­ mones and Lung Cancer held in Marburg, West Germany, on June 18-20, 1984. This volume contains the papers that were pre­ sented on this occasion.
The incidence of lung cancer has reached epidemic proportions throughout the civilized world. One indication of the dimensions of this problem is that in the United States lung cancer has become the leading cause of cancer death in women as well as men. In 1912 there was a nearly complete consensus of opinion that primary malignant neoplasms of the lung (were one) of the rarest forms of disease, according to Adler. By 1937, however, it had become clear that the incidence of lung cancer was increasing significantly; this increase has been progressive ever since. It is now well known that some lung cancers give rise to a variety of hormones which, at times, produce clinical manifestations. The association of hormone production with a nonendocrine tumor raises many questions, the answers to which may shed some light on the etiology of this prevalent form of cancer. This fascinating prob­ lem has stimulated a wide variety of studies in both the clinical and the basic sciences. A number of the more recent studies in this field were discussed at the International Symposium on Peptide Hor­ mones and Lung Cancer held in Marburg, West Germany, on June 18-20, 1984. This volume contains the papers that were pre­ sented on this occasion.
5
Peptide Hormones in Lung Cancer
EN PB NWISBN: 9783540155041 bzw. 354015504X, in Englisch, Springer-Verlag Berlin and Heidelberg GmbH & Co. KG, Taschenbuch, neu.
The incidence of lung cancer has reached epidemic proportions throughout the civilized world. One indication of the dimensions of this problem is that in the United States lung cancer has become the leading cause of cancer death in women as well as men.
6
Peptide Hormones in Lung Cancer (1985)
EN PB NWISBN: 9783540155041 bzw. 354015504X, in Englisch, Springer Berlin Heidelberg, Springer Berlin Heidelberg, Springer Berlin Heidelberg, Taschenbuch, neu.
Lieferung aus: Vereinigte Staaten von Amerika, zzgl. Versandkosten, Free Shipping on eligible orders over $25.
Klaus Havemann (Editor), George D. Sorenson (Editor), Clauss Gropp (Editor),Paperback - Softcover reprint of the original 1st ed. 1985,Series: Recent Results in Cancer Research Series 99, English-language edition,Pub by Springer Berlin Heidelberg.
Klaus Havemann (Editor), George D. Sorenson (Editor), Clauss Gropp (Editor),Paperback - Softcover reprint of the original 1st ed. 1985,Series: Recent Results in Cancer Research Series 99, English-language edition,Pub by Springer Berlin Heidelberg.
7
Symbolbild
Peptide Hormones in Lung Cancer (Recent Results in Cancer Research)
DE USISBN: 9783540155041 bzw. 354015504X, in Deutsch, Springer, Berlin/Heidelberg, Deutschland, gebraucht.
Von Händler/Antiquariat, BookSleuth [58350165], Milpitas, CA, U.S.A.
Peptide Hormones in Lung Cancer (Recent Results in Cancer Research).
Peptide Hormones in Lung Cancer (Recent Results in Cancer Research).
8
Peptide Hormones in Lung Cancer (1985)
DE PB NW RPISBN: 354015504X bzw. 9783540155041, in Deutsch, Springer Berlin Heidelberg; Springer Berlin, Taschenbuch, neu, Nachdruck.
Von Händler/Antiquariat, MARZIES.de Buch- und Medienhandel, 14621 Schönwalde-Glien.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Lade…